This multipart series by Lex Pelger does a deep dive into how these important signaling molecules work.
Chirality may hold the key to turning THC or CBD into even better therapeutics — or alternatively, it might unleash some new hidden dangers.
A molecular biologist deconstructs a cannabis industry myth about CBN as a sleep aid.
A five-part series on the legal limbo of the original peoples of what is now the United States after the passage of the 2018 Farm Bill, which made hemp cultivation again lawful.
Synthetic cannabinoids warrant careful scrutiny in relationship to vaping-related lung injuries.
In early 2019 Project CBD began collecting thousands of responses to a survey designed to figure out who is using CBD, how and why, and whether it’s working for them.
In July 2019 Project CBD submitted comments to the FDA regarding the regulation of CBD and cannabis.
Project CBD has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report is available for free download.
A doctor explores the staggering scope of opioid abuse in America, and a neglected treatment option for opioid addiction: medical cannabis.
This three-part series takes a deep dive into the impact of California’s cannabis after legalization.
Project CBD critiques California’s proposed regulations for cannabis testing regarding pesticides, heavy metals, and solvents and makes recommendations for amending them.
Ten ways that scientists are targeting the endocannabinoid system with synthetic drugs.
Project CBD has created a beginner’s guide for CBD and cannabis therapeutics to address your questions.